naringenin chalcone

RN given refers to cpd with unspecified stereoisomer & from CA Vol 92 Form Index; RN for cpd not in Chemline 7/6/83; structure in first source

Also Known As:

2',4,4',6'-tetrahydroxychalcone; chalconaringenin; naringenin chalcone, (E)-isomer

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Boix Montañés, Antoni: 1 article (01/2019)
2.	Escribano-Ferrer, Elvira: 1 article (01/2019)
3.	Garcia-Sala, Xavier: 1 article (01/2019)
4.	Lamuela-Raventos, Rosa M: 1 article (01/2019)
5.	Queralt Regué, Josep: 1 article (01/2019)
6.	Iwamura, Chiaki: 1 article (03/2010)
7.	Nakayama, Toshinori: 1 article (03/2010)
8.	Obata, Akio: 1 article (03/2010)
9.	Shinoda, Kenta: 1 article (03/2010)
10.	Watanabe, Yukiko: 1 article (03/2010)

1.	Asthma (Bronchial Asthma) 03/01/2010 - "In this study, we investigated the effect of naringenin chalcone in allergic responses in vivo using an experimental mouse model system of allergic asthma. " 03/01/2010 - "Naringenin chalcone suppresses allergic asthma by inhibiting the type-2 function of CD4 T cells."
2.	Inflammation (Inflammations) 03/01/2010 - "Eosinophilic airway inflammation, airway hyperreactivity and Th2 cytokine production from CD4 T cells were significantly suppressed in mice that were treated with naringenin chalcone. " 01/01/2019 - "Quercetin (1.3%) did not exert any topical anti-inflammatory activity in the AA model, but its inhibitory effect in the TPA model was similar to that of naringenin (2%); in contrast, naringenin chalcone was more active against the AA-induced than TPA-induced inflammation. "